Alert Patients About Withdrawal Symptoms With Dopamine Agonists
August 2021
You'll hear about the risk of withdrawal symptoms when stopping dopamine agonists (pramipexole, ropinirole, etc).
These meds are often used for Parkinson's disease, restless legs syndrome, or other conditions, such as excess prolactin or growth hormone secretion.
But some patients who stop or reduce the dose of a dopamine agonist experience dopamine agonist withdrawal syndrome (DAWS).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive